跳至主要内容
临床试验/DRKS00033718
DRKS00033718招募中不适用

Analysis of the gut microbiome of patients with rare monogenic metabolic diseases - MicroMeDi

niversitätsklinikum Heidelberg0 个研究点目标入组 500 人开始时间: 2024年2月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
3 Years 至 one(—)
性别
All

入选标准

  • Children and adults
  • - with confirmed diagnosis of a rare monogenic metabolic disease
  • - who are heterozygous carriers of variants in a gene leading to a rare metabolic disease
  • - who do not carry variants in a gene responsible for a rare monogenic metabolic disease. These serve as healthy controls (age and region matched to the patients)

排除标准

  • - Active or recent illegal substance or alcohol abuse or dependence within the past year.
  • - History of other significant medical disorders apart from rare monogenic metabolic disease (e.g. leukaemia, diabetes mellitus, renal failure…)
  • - Use of antibiotics or probiotics within six months prior to sampling
  • - Individuals having had digestive surgery, are on restrictive diets, or are pregnant

研究者

发起方
niversitätsklinikum Heidelberg

相似试验